The preventive anti-diabetic effect of dangnyosoko (DNSK), a Chinese herbal medicine, was evaluated in STZ-induced diabetic rats. DNSK was orally administered once a day from 3d after STZ-induction at 100, 200, and 500mg/kg for 4 weeks, and the results were compared to those for glibenclamide. Dramatic decreases in body weight and plasma insulin levels and increases in blood and urine glucose levels were detected in STZ-induced diabetic animals with disruption and disappearance of pancreatic islets and increases in glucagon- and decreases in insulin-producing cells. However, these diabetic changes were significantly and dose-dependently inhibited by treatment with DNSK, and DNSK at 100 mg/kg showed more favorable effects than glibenclamide at 5 mg/kg. Based on these results, it is thought that DNSK has favorable effects in ameliorating changes in blood and urine glucose levels and body weight, and that histopathological changes in the pancreas in STZ induce diabetes.
CITATION STYLE
Kim, J. D., Kang, S. M., Park, M. Y., Jung, T. Y., Choi, H. Y., & Ku, S. K. (2007). Ameliorative anti-diabetic activity of Dangnyosoko, a Chinese herbal medicine, in diabetic rats. Bioscience, Biotechnology and Biochemistry, 71(6), 1527–1534. https://doi.org/10.1271/bbb.70058
Mendeley helps you to discover research relevant for your work.